Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › IMVT
SUPERSTRING CAPITAL MANAGEMENT LP position in IMVT
IMMUNOVANT INC · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 208,368 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$8.0M, representing 5.07% of its reported portfolio and ranking #9 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed IMVT holdings in 6 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's IMVT position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in IMVT in Q4 2023 at 203,592 shares (US$8.6M). The position peaked in Q1 2026 at 357,606 shares, worth US$8.9M. Across 6 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 208,368 shares valued at US$8.0M — a reduction of -149,238 shares quarter over quarter.. Notable position changes include a 42% trim in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 203.59K | $8.58M | New |
| Q3 2024 | 12.45K | $354.86K | New |
| Q3 2025 | 341.35K | $5.50M | New |
| Q4 2025 | 288.68K | $7.34M | Reduce |
| Q1 2026 | 357.61K | $8.88M | Add |
| Q2 2026 | 208.37K | $8.03M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMVT and 13F data
IMVT (IMMUNOVANT INC) is a Health Care company. 40 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMVT
- Deep Track Capital, LP 9.34M sh · $359.91M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.80M sh · $223.67M · Q2 2026
- BAKER BROS. ADVISORS LP 5.44M sh · $209.42M · Q2 2026
- TCG Crossover Management, LLC 4.46M sh · $171.77M · Q2 2026
- Two Seas Capital LP 4.61M sh · $155.82M · Q3 2026
- RTW INVESTMENTS, LP 3.18M sh · $122.44M · Q2 2026
- ADAR1 Capital Management, LLC 2.33M sh · $89.80M · Q2 2026
- Alpine Global Management, LLC 1.38M sh · $52.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.36M sh · $52.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $46.24M · Q2 2026
- Logos Global Management LP 665.00K sh · $25.62M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held IMVT?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed IMVT holdings in 6 of the last 11 reported quarters, going back to Q4 2023.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in IMVT?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 208.37K shares of IMVT (IMMUNOVANT INC), valued at $8.03M, representing 5.07% of its reported portfolio and ranking #9.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling IMVT?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP reduced its position in IMVT. The position peaked in Q1 2026 at 357.61K shares.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.